title: P1(A2/Ra)-purinoceptors may mediate the stimulatory effect of adenosine and adenosine analogs on acid formation in isolated rabbit parietal cells.
abstract: The effects of adenosine (ADO) and its analogs 2-chloroadenosine (2CADO) and 5'-N-ethyl-carboxamido adenosine (NECA) on acid production, as measured by the [14C]-aminopyrine (AP) accumulation method, were studied in rabbit gastric parietal cells prepared by enzymatic dispersion and enriched by counterflow elutriation. ADO (1 microM to 1 mM), 2CADO (1 microM to 1 mM) and NECA (0.1 microM to 100 microM) caused significant concentration-related increases on AP uptake by resting parietal cells. The order of potency was NECA >> 2CADO > or = ADO. Histamine and dibutyryl-cAMP (db-cAMP), known secretagogues, stimulated AP accumulation. In both, histamine- and db-cAMP-stimulated parietal cells, ADO, 2CADO and NECA at the above concentration ranges induced concentration-related increases of the respective AP accumulation raised-rates. The rank order of potency in both stimulated conditions was: NECA > 2CADO >> ADO. Cimetidine, a well known H2 histamine receptor antagonist, at concentration of 100 microM caused potent inhibition of histamine-stimulated AP accumulation without affecting the stimulatory responses to db-cAMP. The increases of AP accumulation elicited by NECA, the most potent purine tested, in both resting and histamine- or db-cAMP-stimulated parietal cells were not significantly modified by cimetidine 100 microM. Theophylline (0.1 microM to 10 microM), a non-specific P1-purinoceptor antagonist, caused significant inhibition of the NECA responses in both resting and histamine-stimulated parietal cells. The concentration order of potency of theophylline was: 0.1 microM > 1 microM > 10 microM. These results suggest that there are P1(A2/Ra)-purinoceptors on rabbit parietal cells which mediate the stimulatory effects of adenosine and analogs on gastric acid production.
authors.affiliation: Departamento de Fisiología, Facultad de Medicina, Universidad del País Vasco (UPV-EHU), Bilbao, Spain.
authors.forename: L F
authors.initials: LF
authors.lastname: Ainz
authors.forename: C
authors.initials: C
authors.lastname: Salgado
authors.forename: J M
authors.initials: JM
authors.lastname: Gandarias
authors.forename: R
authors.initials: R
authors.lastname: Gomez
authors.forename: A
authors.initials: A
authors.lastname: Vallejo
authors.forename: C E
authors.initials: CE
authors.lastname: Gil-Rodrigo
mesh_terms: D015762:2-Chloroadenosine / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology*; D019830:Adenosine-5'-(N-ethylcarboxamide); D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D010295:Parietal Cells, Gastric / Q000187:drug effects*; D011817:Rabbits; D011983:Receptors, Purinergic / Q000378:metabolism*
chemical_list: D006635:Histamine H2 Antagonists; D011983:Receptors, Purinergic; D000632:Aminopyrine; D015762:2-Chloroadenosine; D019830:Adenosine-5'-(N-ethylcarboxamide); D003994:Bucladesine; D006632:Histamine; D000241:Adenosine